Guardant Health, Inc. - Common Stock (GH)

Historical Holders from Q4 2018 to Q3 2025

Symbol
GH on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
124M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
122M
Holdings value
$7.65B
% of all portfolios
0.011%
Grand Portfolio weight change
0%
Number of holders
385
Number of buys
197
Number of sells
-172
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Guardant Health, Inc. - Common Stock (GH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% $460M 9.29M BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 4.41% $270M 5.44M Deep Track Capital, LP 31 Mar 2025
CADIAN CAPITAL MANAGEMENT, LP 4.2% $259M 5.22M Cadian Capital Management, LP 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 3.9% $240M 4.85M Wellington Management Group LLP 31 Dec 2024

Institutional Holders of Guardant Health, Inc. - Common Stock (GH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 122M $7.65B -$62.8M $62.48 385
2025 Q2 124M $6.47B +$331M $52.04 359
2025 Q1 118M $5.05B +$16M $42.60 336
2024 Q4 119M $3.65B -$153M $30.55 294
2024 Q3 125M $2.86B +$193M $22.94 264
2024 Q2 115M $3.32B +$180M $28.88 274
2024 Q1 111M $2.3B -$29.7M $20.63 252
2023 Q4 110M $2.98B +$46M $27.05 289
2023 Q3 108M $3.21B -$83.6M $29.64 289
2023 Q2 110M $3.94B +$695M $35.80 293
2023 Q1 92.6M $2.17B -$17M $23.44 271
2022 Q4 94.3M $2.56B -$200M $27.20 280
2022 Q3 95M $5.11B +$162M $53.83 310
2022 Q2 92.8M $3.75B -$40M $40.34 310
2022 Q1 92.4M $6.11B -$81.9M $66.24 335
2021 Q4 92.1M $9.21B -$251M $100.02 379
2021 Q3 94.1M $11.8B +$583M $125.01 365
2021 Q2 89.6M $11.1B -$275M $124.19 410
2021 Q1 91.4M $13.9B +$681M $152.65 410
2020 Q4 87.4M $11.3B +$219M $128.88 399
2020 Q3 85.4M $9.55B +$176M $111.78 341
2020 Q2 84.3M $6.84B +$491M $81.13 311
2020 Q1 78.3M $5.45B +$31.1M $69.60 281
2019 Q4 77.1M $6.02B +$259M $78.14 261
2019 Q3 73.8M $4.71B -$155M $63.83 230
2019 Q2 76M $6.56B +$1.41B $86.33 214
2019 Q1 60.3M $4.62B +$11.8M $76.70 144
2018 Q4 61.7M $2.32B +$2.05B $37.59 87